Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 18Unknown 5Recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Malignant Hepatobiliary Neoplasm 1Gastrointestinal Neoplasms 1Fatigue 1Caregiver Burden 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Acceptance and Commitment Therapy × Clear all
NCT06532877 2026-01-23

Telephone Support in Advanced Gastrointestinal Cancer

Indiana University

Phase NA Recruiting
488 enrolled
Gastrointestinal

Caregiver Burden, Fatigue, Gastrointestinal Neoplasms

NCT07124546 2025-08-15

Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers

Mayo Clinic

Phase NA Recruiting
60 enrolled
Gastrointestinal

Malignant Hepatobiliary Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡